GSDMD and Hepatic fibrosis: Since NSA is also reported as inhibitor of GSDMD-mediated pyroptosis [49–51], which is also involved in liver injury/fibrosis [52], we consider that NSA is likely to attenuate BDL-induced liver fibrosis via inhibiting pyroptosis (maybe not necroptosis).